ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed
Suhasini Joshi
Matched on ORCID iD 0000-0002-6698-1193; OpenAlex author ID A5079149368. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2012: 1 paper · 2013: none · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 5
- Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma. Co-author DOI 10.1073/pnas.1920240117↗
- Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. Co-author DOI 10.1016/j.molonc.2016.04.007↗
- Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages. Co-author DOI 10.1038/onc.2014.154↗
- Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.3912↗
- Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering c… Co-author DOI 10.1016/j.canlet.2012.03.031↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 4 shared papers, 2012–2016 · strength 0.18
- Paper Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. DOI 10.1016/j.molonc.2016.04.007↗
- Paper Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. DOI 10.18632/oncotarget.3912↗
- Paper Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression … DOI 10.1038/onc.2014.154↗
- Satyanarayana Rachagani · 4 shared papers, 2012–2016 · strength 0.18
- Paper Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. DOI 10.1016/j.molonc.2016.04.007↗
- Paper Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. DOI 10.18632/oncotarget.3912↗
- Paper Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression … DOI 10.1038/onc.2014.154↗
- Moorthy Palanimuthu Ponnusamy · 2 shared papers, 2015–2016 · strength 0.11
- Sushil Kumar K · 2 shared papers, 2015–2016 · strength 0.10
- Matilda Holm · 1 shared paper, 2020 · strength 0.10
- Olivera Grbovic-Huezo · 1 shared paper, 2020 · strength 0.10
- Gökçe Aşkan · 1 shared paper, 2020 · strength 0.10
- Kenneth L Pitter · 1 shared paper, 2020 · strength 0.10
- Caj H. Haglund · 1 shared paper, 2020 · strength 0.10
- Tuomas Tammela · 1 shared paper, 2020 · strength 0.10
- Steven D Leach · 1 shared paper, 2020 · strength 0.10
- Rohit Chandwani · 1 shared paper, 2020 · strength 0.10
- Christine A. Iacobuzio–Donahue · 1 shared paper, 2020 · strength 0.10
- Maneesh Jain · 2 shared papers, 2015 · strength 0.09
- Apar Kishor Ganti · 2 shared papers, 2012–2015 · strength 0.07
- María P. Torres · 2 shared papers, 2012–2015 · strength 0.07
- Paper Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression … DOI 10.1038/onc.2014.154↗
- Paper Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells… DOI 10.1016/j.canlet.2012.03.031↗
- Randall E. Brand · 1 shared paper, 2016 · strength 0.06
- Sushovan Guha · 1 shared paper, 2016 · strength 0.06
- Parthasarathy Seshacharyulu · 1 shared paper, 2015 · strength 0.05
- Suprit Gupta · 1 shared paper, 2015 · strength 0.05
- Dhanya Haridas · 1 shared paper, 2015 · strength 0.05
- Imayavaramban Lakshmanan · 1 shared paper, 2015 · strength 0.05
- Ying Yan · 1 shared paper, 2015 · strength 0.05
- Chittibabu Guda · 1 shared paper, 2015 · strength 0.05
- Navneet Momi · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.